08 Dec 2021 MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis Member news
07 Dec 2021 Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study Member news
07 Dec 2021 Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion Member news
06 Dec 2021 New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster Member news
06 Dec 2021 Celyad Oncology announces $32.5 million private placement with Fortress Investment Group Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
